NovaBridge Biosciences NBP
NASDAQ NBP
$1.36 +0.02 (+1.49%)
At close: Oct 2, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Income from Discontinued Operations (2023 - 2024)

Updated

NovaBridge Biosciences' Income from Discontinued Operations came in at $34.36 million for Q4 2024, compared with -$30.99 million a year earlier.

Analysis

NovaBridge Biosciences (NBP) Income from Discontinued Operations (2023 - 2024) Analysis & Trends

For FY2024, NovaBridge Biosciences' Income from Discontinued Operations was $27.47 million.

  • Going back by year, Income from Discontinued Operations was -$125.51 million in FY2023 and -$229.85 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 8.00 Mn
10 NovaBridge Biosciences 149.78 Mn 149.78 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 34.36 Mn
Jun 30, 2024 180.00
Mar 31, 2024 -6.90 Mn
Dec 31, 2023 -30.99 Mn
Sep 30, 2023 -25.04 Mn
Jun 30, 2023 -33.91 Mn
API Access

NovaBridge Biosciences Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=NBP&period=max&api_key=YOUR_API_KEY